RBS News and Press, Royal Bank of Scotland Group Plc New ADS From 12/17/19

Proteostasis Therapeutics (NASDAQ: PTI )  -37%  on mixed results in mid-stage CF study. More news on: Proteostasis Therapeutics, Inc., MEI Pharma, Inc., VistaGen Therapeutics, Inc., Stocks on the move, Read more ...

Shares of Royal Bank of Scotland Group (NYSE: RBS) traded up more than 10% on Friday morning, part of a broader rally in British stocks following the Conservative Party's election victory in the United Kingdom. The vote should relieve much of the uncertainty surrounding Brexit and caused the...

Sarepta Therapeutics (NASDAQ: SRPT )  +31%  on FDA nod for golodirsen. More news on: Sarepta Therapeutics, Inc., BioLineRx Ltd., The Royal Bank of Scotland Group plc, Stocks on the move, Read more ...

Lloyds Banking Group ( LYG ) has delivered relatively weak results in 2019, but this is explained by one-off PPI charges that aren't expected to be an issue going forward. Its underlying performance remains strong and the dividend sustainability remains good, thus Lloyds' investment case mai...

This article was selected to be shared with PRO+ subscribers - find out more here . Introduction Lloyds ( LYG ) is a long-term holding in our portfolio , but the share price has been volatile due to the uncertainties around Brexit. Year-to-date, Lloyds has been the best performer (alon...

Editor's note: Seeking Alpha is proud to welcome Quant Student as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » Thesis The po...

The Royal Bank of Scotland Group plc (RBS) Q3 2019 Earnings Conference Call October 24, 2019 04:00 AM ET Company Participants Katie Murray - Chief Financial Officer Conference Call Participants Jonathan Pierce - Numis Raul Sinha - JPMorgan Martin Leitgeb - Goldman Sachs F...

The following slide deck was published by The Royal Bank of Scotland Group plc in conjunction with their 2019 Q3 earnings Read more ...

Royal Bank of Scotland (NYSE: RBS )  falls 3.5%  in premarket trading after reporting an unexpected operating loss before tax of £8M ($10.3M) in Q3 vs. expected operating profit of £720M  ($928M). More news on: The Royal Bank of Scotland Group plc, Financia...

The Royal Bank of Scotland (NYSE: RBS ): Q3 net loss of £20M Total income of £106M (-46.5% Y/Y) Shares  -3.6% Press Release More news on: The Royal Bank of Scotland Group plc, Earnings news and commentary, Financial stocks news,